| Specialty Retail Industry | Consumer Discretionary Sector | Patrick Waty CEO | OTC PINK Exchange | GB00BGHPT808 ISIN |
| GB Country | 800 Employees | - Last Dividend | - Last Split | - IPO Date |
Benchmark Holdings plc is a company rooted in the agricultural and food production industries, offering a wide range of technical services, products, and specialized knowledge to support the sustainable development of these sectors. Established in 2000 and based in Sheffield, United Kingdom, the company has a diversified operational structure, segmented into Genetics, Advanced Nutrition, and Health. These segments cater to different needs within the aquaculture industry by harnessing advanced breeding technologies, nutrition and health products, and eco-friendly solutions to address challenges faced by the industry globally. Benchmark Holdings plc has a widespread international presence, with operations and facilities spanning across the United Kingdom, Norway, Vietnam, Iceland, the Faroe Islands, China, Ecuador, India, Canada, Greece, Chile, Turkey, other European countries, and beyond.
The offerings of Benchmark Holdings plc are organized into three main segments:
This segment is focused on the provision of breeding technologies and production facilities for sea bass and bream, salmon, and shrimp. Through its advanced genetic solutions, Benchmark offers high genetic merit ova (eggs) to the aquaculture industry, enhancing the productivity, efficiency, and sustainability of farming operations across the globe.
Under this segment, Benchmark manufactures and supplies a comprehensive range of nutrition and health products tailored for the aquaculture sector. The aim is to improve the overall health and growth rates of aquatic species, contributing to the efficiency and economic performance of aquaculture enterprises.
Benchmark’s Health segment offers a variety of health products designed to combat common diseases and parasites affecting aquaculture species. Notably, products like Ectosan Vet and CleanTreat are innovative solutions targeting sea lice, a prevalent parasite in farmed salmon. These solutions are developed to ensure the welfare of aquatic animals while minimizing environmental impact, marking a significant advancement in medicinal treatments within the aquaculture market.